Menegatti, M., Palla, R., Boscarino, M. et al. (6 more authors) (2017) Minimal factor XIII activity level to prevent major spontaneous bleeds. Journal Of Thrombosis And Haemostasis, 15 (9). pp. 1728-1736. ISSN 1538-7933
Abstract
BACKGROUND: Congenital factor XIII (FXIII) deficiency is a rare bleeding disorder associated with significant bleeding manifestations. The European Network of Rare Bleeding Disorders (EN-RBD) study, performed from 2007 to 2010, showed a strong association between bleeding severity and FXIII activity in plasma of patients with FXIII deficiency. Among these patients variable levels of FXIII activity, from undetectable to 30%, were associated with a wide range of bleeding severity. Objectives and patients: The present cross-sectional study, in the frame of the PRO-RBDD project, a prospective cohort study, analyzed data of 64 patients with FXIII deficiency and different types of clinical and laboratory severity. RESULTS: The results of this analysis confirmed that FXIII coagulant activity in plasma is well associated with clinical severity of patients. In addition, 15 IU/dl of FXIII activity was identified to be the level under which the probability of spontaneous major bleeding sharply increases (from 50% for levels of 15 IU/dL to more than 90% for levels of 5 IU/dL or lower). CONCLUSION: the PRO-RBDD study suggests a FXIII coagulant activity level of 15 IU/dL as a target to start prophylaxis in order to prevent major bleedings, such as central nervous system or gastrointestinal tract hemorrhages.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | This is the peer reviewed version of the following article: Menegatti, M., Palla, R., Boscarino, M., Bucciarelli, P., Muszbek, L., Katona, E., Makris, M., Peyvandi, F. and On behalf of the PRO-RBDD study group (2017), Minimal factor XIII activity level to prevent major spontaneous bleeds. Journal of Thrombosis and Haemostasis , which has been published in final form at https://doi.org/10.1111/jth.13772. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. |
Keywords: | Factor XIII; Factor XIII deficiency; Haemorrhage; Phenotype; Prophylaxis |
Dates: |
|
Institution: | The University of Sheffield |
Academic Units: | The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Infection, Immunity and Cardiovascular Disease The University of Sheffield > Sheffield Teaching Hospitals |
Funding Information: | Funder Grant number EUROPEAN COMMISSION (NON FRAMEWORK) EUHANET - 2011 12 07 |
Depositing User: | Symplectic Sheffield |
Date Deposited: | 18 Jul 2017 11:14 |
Last Modified: | 24 Oct 2023 14:56 |
Published Version: | https://doi.org/10.1111/jth.13772 |
Status: | Published |
Publisher: | Wiley |
Refereed: | Yes |
Identification Number: | 10.1111/jth.13772 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:119099 |